Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Align Technology    ALGN

ALIGN TECHNOLOGY

(ALGN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Align Technology : There is still some upside potential

share with twitter share with LinkedIn share with facebook
share via e-mail
08/13/2019 | 09:52am EDT
long trade
Live
Entry price : 180.28$ | Target : 239$ | Stop-loss : 169.4$ | Potential : 32.57%
Shares in Align Technology do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Investors have an opportunity to buy the stock and target the $ 239.
Chart ALIGN TECHNOLOGY
Duration : Period :
Align Technology Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • Align Technology accounts for 4.33 % of our USA Portfolio. A trade is currently open since 08/01/2019 with a purchase price of $ 206.40. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.

Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 186.71 USD in weekly data.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the USD 157.26 support.
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses
  • Based on current prices, the company has particularly high valuation levels.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.74 times its estimated earnings per share for the ongoing year.
  • Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart
Subsector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
ALIGN TECHNOLOGY-15.35%13 927
MEDTRONIC PLC11.86%136 463
BAXTER INTERNATIONAL INC.32.13%43 795
HOYA CORPORATION29.55%29 718
ZIMMER BIOMET HOLDINGS32.10%27 744
TERUMO CORP-45.97%23 173
DEXCOM, INC.36.63%14 456
SARTORIUS STEDIM BIOTECH53.86%13 541
STERIS PLC42.23%12 870
SYSMEX CORP20.99%12 464
SARTORIUS AG (PREFERENCE)58.13%12 093
Autres valeurs du secteur

David Meurisse
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2019 2 382 M
EBIT 2019 512 M
Net income 2019 417 M
Finance 2019 676 M
Yield 2019 -
P/E ratio 2019 34,3x
P/E ratio 2020 27,5x
EV / Sales2019 5,66x
EV / Sales2020 4,57x
Capitalization 14 160 M
Upcoming event on ALIGN TECHNOLOGY
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 259,00  $
Last Close Price 177,29  $
Spread / Highest target 80,5%
Spread / Average Target 46,1%
Spread / Lowest Target 9,99%
EPS Revisions
Managers
NameTitle
Joseph M. Hogan President, Chief Executive Officer & Director
Ray Larkin Chairman
Emory M. Wright Senior Vice President-Global Operations
John F. Morici CFO, Principal Accounting Officer & SVP-Finance
Zelko Relic Chief Technology Officer